Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
MOTS-c targets AMPK-dependent insulin sensitization Regulatory status / FDA lists both peptides among bulk drug substances under evaluation for compounding Why No Direct Comparison Exists Neither AOD-9604 nor MOTS-c has advanced far enough in clinical development for a randomized head-to-head trial
If side effects persist or significantly impact your comfort, consult your healthcare provider
/
It comes in the multi-dose Mounjaro Kwikpen format and clinical trials (SURMOUNT) show it helps in up to 22% mean body weight reduction at the 15mg dose over 72 weeks
US$ 23.30
US$ 20.58
US$ 21.51
US$ 26.49
US$ 22.93
US$ 20.25
US$ 27.82
